PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision.

• The company has unveiled a Server Pod design concept aimed at demonstrating how its factory could be used to manufacture custom enclosures for AI and cloud-computing infrastructure.
• BOXABL is not currently manufacturing or selling Server Pods; the concept is intended to attract data center developers and equipment companies for potential custom projects.
• JLL projects approximately 100 gigawatts of new global data center capacity could come online between 2026 and 2030, requiring as much as $3 trillion in investment.
• BOXABL believes factory assembly could address some of the industry’s construction constraints, particularly rising costs and lengthy deployment timelines.
• The company’s conceptual designs range from compact 10-foot and 20-foot units to larger 40-foot configurations and a proposed 2,500-square-foot “Server Tron.”
• The initiative gives BOXABL a potential avenue to apply its manufacturing infrastructure beyond its core housing business and into a rapidly expanding AI infrastructure market.

BOXABL (NASDAQ: BXBL), an innovative technology company transforming the housing market with its modular building systems, is testing the boundaries of its factory-built construction model with a new concept aimed at one of the fastest-growing infrastructure markets: data centers. The company unveiled its Server Pod concept on August 20, presenting a series of factory-assembled enclosure designs intended to house AI and cloud-computing infrastructure (https://ibn.fm/SzTtf).

The announcement is not the launch of a new commercial product. BOXABL has not begun manufacturing Server Pods and is not offering them for sale. Instead, the company is using the concept to demonstrate what its existing factory infrastructure could potentially build for data center customers and to invite developers and equipment manufacturers to discuss custom projects.

The timing reflects a significant change taking place in the data center industry. According to JLL’s 2026 Global Data Center Market Outlook, global data center capacity is expected to expand by roughly 100 gigawatts between 2026 and 2030, nearly doubling existing capacity. JLL estimates that accommodating this expansion could require approximately $3 trillion in investment, including real estate development and spending on servers, GPUs and networking equipment.

Construction itself is becoming more expensive. JLL reports that data center construction costs have increased at approximately a 7% compound annual growth rate since 2020. At the same time, access to electricity has become a major constraint. Developers in some primary markets face grid-connection waiting periods exceeding four years, making speed to power an increasingly important consideration when selecting sites.

For data center operators, therefore, the challenge is not simply securing land and installing computing equipment. The physical infrastructure needed to house that equipment has to be delivered quickly enough to keep pace with demand.

That is where BOXABL’s manufacturing model enters the discussion. The company’s core proposition is to move construction activity from a conventional job site into a controlled factory environment. Rather than assembling an entire structure from raw materials at its final location, BOXABL manufactures building components in a production setting before transporting them to the site.

The Server Pod concept extends that philosophy to compute infrastructure. BOXABL has illustrated several conceptual configurations, ranging from a 10-foot enclosure envisioned around eight racks to a 40-foot configuration with 36 racks. A larger 2,500-square-foot concept, called “Server Tron,” illustrates how the same factory-built approach could potentially scale to larger deployments.

These are design-study targets, not specifications for a manufactured product. Any actual deployment would require project-specific engineering, equipment selection, permitting and validation of local conditions.

The proposed architecture also reflects the specialized requirements of data centers. The concepts contemplate insulated building envelopes, filtered-air and liquid-cooling approaches, pre-installed racks and factory-level preparation intended to reduce the amount of work required after delivery. Units could potentially be transported on structural pallet frames and positioned on prepared sites. In practice, the final configuration would depend on the customer’s computing hardware, power requirements, cooling system, local building codes and site conditions.

The opportunity is particularly relevant as AI workloads continue to drive demand for computing capacity. JLL estimates that AI accounted for approximately a quarter of data center workloads in 2025. The research firm expects the mix of workloads to evolve as AI inference becomes increasingly important, potentially pushing some computing requirements closer to end users and regional markets rather than keeping all workloads concentrated in the largest centralized facilities. That could increase demand for distributed computing infrastructure.

For BOXABL, a factory-based manufacturing process could potentially be useful in that environment because repeatable structures can be produced away from congested construction sites and delivered to locations where additional computing capacity is required.

The company is therefore seeking conversations with data center developers, hyperscalers, colocation providers and equipment manufacturers. Any commercial opportunity would require a separate agreement under which BOXABL would design and manufacture a structure according to a customer’s requirements.

The initiative also illustrates how BOXABL is attempting to broaden the potential application of its manufacturing infrastructure while retaining its central focus on housing.

BOXABL was established around the idea that housing could benefit from manufacturing-style production. Its best-known product, the Casita, is a 361-square-foot modular unit designed to be manufactured in a factory and deployed on site. The company has positioned that model as an alternative to conventional site-built construction, with an emphasis on production efficiency and scalability.

For more information, visit the company’s website at www.Boxabl.com.

NOTE TO INVESTORS: The latest news and updates relating to BXBL are available in the company’s newsroom at https://ibn.fm/BXBL

Cautionary Note Regarding the Business Combination and Capital Structure. BOXABL Inc. became a publicly traded company through a business combination with FG Merger II Corp., a special purpose acquisition company, completed in July 2026, with the shares beginning trading on the Nasdaq Stock Market under the symbol BXBL on July 20, 2026. Companies that become public through special purpose acquisition transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and redemption-related capital reductions. In July 2026 the Company filed a universal mixed shelf registration statement that would permit it to offer up to $500,000,000 of securities over time; any such issuance would be dilutive to existing holders. References to capital raised since inception and to the number of investors are as disclosed by the Company. Readers should review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov, including its periodic reports, in full.

Cautionary Note Regarding Forward-Looking Statements. This publication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including projections of market opportunity and market share, estimates of customer adoption, projections of development and commercialization costs and timelines, expectations regarding the Company’s ability to execute its business model, the deployment of the Casita, the development and potential production of the Baby Box and of stackable and connectable modules, the pursuit of additional state regulatory approvals, expectations concerning relationships with customers, developers, strategic partners, suppliers, governments and regulatory bodies, and the potential for future projects. Such statements are generally identified by words such as “plan”, “project”, “will”, “estimate”, “intend”, “expect”, “believe”, “target”, “continue”, “could”, “may”, “might”, “possible”, “potential” or “predict”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual circumstances, events, or results to differ materially, including manufacturing, supply chain, permitting, regulatory, financing, dilution, listing, competitive and market risks, and other risks identified in the Company’s filings with the Securities and Exchange Commission. Do not place undue reliance on such statements. The forward-looking statements in this publication are made as of the date above and IBN undertakes no obligation to update them.

Full Disclaimer. NetworkNewsWire (“NNW”) is a division of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company. IBN has been compensated for advertising and digital media services for BOXABL Inc. This publication is for informational purposes only and is not, and should not be construed as, a research report, investment advice, or a recommendation to buy or sell any security. The information contained herein is believed to be reliable but no guarantee can be made as to its accuracy or completeness. Neither IBN nor NNW is registered as an investment adviser or broker-dealer. Readers should review BOXABL Inc.’s filings with the U.S. Securities and Exchange Commission and consult with a licensed financial advisor before making any investment decision. Please see the full terms of use and disclaimers applicable to all content provided by IBN, wherever published or re-published, at https://IBN.fm/Disclaimer.

• Utility power for large data centers can take years to secure, and demand continues to rise faster than the grid can expand to meet it.
• Atlas One is Azio AI Holdings’ answer to that pressure; the project spans more than 548 acres in south Texas and is engineered for up to 500 megawatts of planned behind-the-meter power capacity.
• The name Atlas One reflects a broader naming convention the company plans to use going forward, tying separate land, power and fiber updates together under one project.

Building an AI data center is no longer just about buying enough graphical processing units (“GPUs”); rather, it is about finding enough electricity to run them. Azio AI Holdings (NASDAQ: AZIO) is committed to addressing that challenge, and just announced its Atlas One project, a South Texas compute campus designed around power the company generates itself.

Utility power for large data centers can take years to secure, and demand continues to rise faster than the grid can expand to meet it. Goldman Sachs Research projects U.S. data center power demand will climb from 31 gigawatts in 2025 to 66 gigawatts in 2027. That gap has pushed developers toward on-site power generation as a way to control their own construction timelines.

Atlas One is Azio AI Holdings’ answer to that pressure. The project spans more than 548 acres in south Texas and is engineered for up to 500 megawatts of planned behind-the-meter power capacity. The company has already secured approximately 11 megawatts of behind-the-meter natural gas generation and supporting electrical infrastructure at the site. 

About 6 megawatts of that secured power has been already been activated to run compute infrastructure, the company has reported. That activated 6 megawatts has run a Bitcoin mining workload as an initial test of the power system, achieving roughly 97.8% uptime, with the company noting that the figure reflects a mining workload rather than a service-level commitment for AI or high-performance computing customers.

Azio AI Holdings has also committed approximately $2.4 million to a master services agreement with AT&T for dedicated enterprise fiber at the site, part of the connectivity buildout supporting the project. Natural gas pipeline and metering infrastructure is under development alongside it, the company said.

The name Atlas One reflects a broader naming convention the company plans to use going forward. Azio AI Holdings said future sites will be named Atlas Two, Atlas Three and so on as they are announced, tying separate land, power and fiber updates together under one project. “We have been building Atlas One for months,” stated Azio AI CEO Chris Young. “Naming it is how we make clear to the market that the land, the power, the fiber and the compute are one project on one site, not a collection of separate announcements.”

Beyond Atlas One, Azio AI Holdings’ broader business includes GPU hardware sales and hosting agreements, though the company said those are structured as separate commercial arrangements. That includes an agreement to sell up to 512 NVIDIA HGX B300 GPU systems to Power Champion Investment Limited, worth an estimated $307 million. That agreement supplements previous hosting agreements with Power Champion, which the company said reflects the type of hosting demand Atlas One is being built to serve. 

Azio AI Holdings’ near-term priorities include finishing infrastructure for its initial 11 megawatt phase, advancing natural gas pipeline work and completing fiber connectivity under the AT&T agreement. The company plans to pursue customer hosting and offtake agreements as that infrastructure comes online; the company noted that realizing its full 500 megawatt vision will require additional generation, equipment, permitting, financing and customer commitments that are not yet in place. 

Azio AI Holdings framed Atlas One as connecting two sides of its business — GPU hardware sales and physical hosting infrastructure — rather than treating them as separate ventures. Company officials believe that hardware relationships, such as the one with Power Champion, may eventually create demand for the hosting capacity Atlas One is being built to provide.

For now, Atlas One is a construction and permitting story, working toward becoming an operating one. Its progress over the coming months, particularly as the initial 11 megawatt phase gets built out and contracted, will show whether Azio AI Holdings can turn a power-first strategy into paying AI customers.

For more information, visit www.AzioAI.ai.

NOTE TO INVESTORS: The latest news and updates relating to AZIO are available in the company’s newsroom at https://ibn.fm/AZIO

Date: October 7, 2026

Venue: City Winery, New York City

In its second year, leading investor social platform Stocktwits’ Stocktoberfest gathering is moving to the center of the financial universe — New York City — for its gathering of traders, investors, public company executives, financial professionals, and content creators, to generate real conversations that move markets and build lasting relationships.

On Oct. 7, Stocktwits will sponsor programming of panels and fireside chats at the City Winery designed to address everything from macro trends to the future of retail investing with market leaders, traders and executives.

Stocktwits is offering a one-day pass to the main investor conference, which includes discussions of the following:

• Real historical crowd calls, revealed before the market knew the outcome
• Data, distribution and sentiment — not the trading UI — becoming the next moat
• How AI agents source signal, and the value of community-generated sentiment data
• How companies communicate to both human investors and their AI agents
• Top retail voices on building real communities and trust that algorithms can’t match

The day will begin with a breakfast gathering, followed by the keynote fireside chat with Barry Ritholtz, the co-founder, chairman, and chief investment officer of financial planning and asset management firm Ritholtz Wealth Management LLC, which has more than $9.4 billion in assets under management.

The lineup also features additional fireside chats, including two that focus on market strategies for individual investors and their portfolios:

• Social Arbitrage and the Democratization of Investing
• Private Markets: Getting In Before the Story Is Public

The event also fosters networking opportunities to build connections that will “compound over time,” according to the organizers. The programming is the culmination of Stocktwits’ month-long celebration that brings the spirit of Oktoberfest to the markets with community-driven content, interactive features and live events across newsletters, video shows and social media.

The role of artificial intelligence in the evolving marketplace is a core theme of the gathering. Whether in finance, the crypto markets, options trading, retail investor trends or the development of financial media, AI is expected to be a key player in the years to come.

To learn more, including additional package option details, please visit https://ibn.fm/hesEu.

• The program began with a robotic left internal mammary artery (“LIMA”) take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra advanced robotic surgical system from SS Innovations.
• SS Innovations reported 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025.
• The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka and the Philippines.
• SS Innovations is pursuing U.S. FDA review and European Union CE marking as it seeks to expand SSi Mantra into additional international markets.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. The program began with a robotic cardiac surgery LIMA take-down performed using the SSi Mantra 3.0 system. The procedure was led by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, with support from the SS Innovations team.

“We congratulate Dr. Brajmohan Sinh, Dr. Lalit Malik, and the entire team at HCG Hospital for this achievement, and thank them for their trust and commitment in advancing robotic cardiac surgery in the region,” the company wrote in a LinkedIn post (https://ibn.fm/TTTdR). “At SS Innovations International, Inc. we remain committed to enabling hospitals and surgical teams across the country to bring advanced, affordable robotic surgery to more patients, in more places.”

The Ahmedabad deployment adds another cardiac program to an installed base that is increasingly being used across specialties and geographies. The announcement comes shortly after SS Innovations reported that 238 SSi Mantra systems had been installed as of September 8, compared with 168 at the end of 2025. That represents a 42% increase in the installed base during the period.

Procedure volumes have grown more rapidly. The company reported 14,103 cumulative multi-specialty procedures using SSi Mantra as of September 8, up from 7,885 at the end of 2025, an increase of 79%. Approximately 1,500 physicians have been trained on the system, which has been used for more than 170 different types of surgical procedures.

The figures provide a measure of the operating base SS Innovations has established in India while the company works to replicate that model internationally. In July, SS Innovations launched a robotic cardiac surgery program at La Fundación Cardiovascular de Colombia in Bucaramanga. The program included Colombia’s first Totally Endoscopic Beating-Heart Bypass Surgery performed using SSi Mantra.

In August, Kings Hospital Colombo installed the first SSi Mantra system in Sri Lanka. The company subsequently reported the country’s first robotic-assisted cardiac surgery using the platform, followed by more than 25 additional robotic procedures during the system’s first three weeks of operation.

With the Sri Lankan installation, SS Innovations said the SSi Mantra’s installed base had reached 12 countries.

The company is also extending the platform into pediatric procedures. On August 14, SSi Mantra and 5-millimeter instruments were used for a robotic pyeloplasty on a 45-day-old infant at Hindusthan Hospital in Coimbatore, India. SS Innovations reported 258 cumulative pediatric robotic surgeries as of August 31.

Telesurgery represents another developing application. As of August 31, the company reported 188 robotic telesurgeries using SSi Mantra. One July procedure connected surgeons at Hospital Internacional de Colombia in Bucaramanga with a patient at Mohak Bariatrics and Robotics in Indore, India, across more than 13,600 miles of fiber-network distance.

In September, SSi Mantra was also used for what the company described as the first telesurgery within the Philippines, connecting Pampanga and Cotabato across approximately 1,710 kilometers.

SS Innovations is positioning SSi Mantra around both advanced surgical capabilities and accessibility. The platform is a modular system with three to five robotic arms, a 3D 4K visualization system and more than 40 types of robotic endo-surgical instruments, according to the company. Its product range also includes the SSi Mudra instrument portfolio and the portable MantrAsana tele-surgeon console.

The next major development area is regulatory expansion. SS Innovations submitted its SSi Mantra 510(k) premarket notification to the U.S. Food and Drug Administration in December 2025. The company now expects the FDA review to be completed by the end of the first quarter of 2027. It also believes the SSi Mantra can obtain European Union CE marking by the end of 2026.

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• The FDA IND approval marks a pivotal step for the company’s lead compound, known as Lucid-MS.
• What sets Quantum BioPharma’s proprietary treatment apart from most existing MS therapies is its mechanism.
• Lucid-MS previously completed phase 1 clinical trials, showing a favorable safety profile and being well tolerated.

A green light from the U.S. Food and Drug Administration (“FDA”) can turn years of laboratory work into a real shot at treating patients, and that is exactly what just happened for one biopharmaceutical company. Quantum BioPharma (NASDAQ: QNTM), a company focused on neurodegenerative and metabolic disorders, announced that the FDA has approved its Investigational New Drug (“IND”) application for Lucid-MS, clearing the path to phase 2 clinical testing of its multiple sclerosis (“MS”) candidate.

The announcement marks a pivotal step for the company’s lead compound, known as Lucid-MS. With the IND now approved, Quantum BioPharma can begin recruiting patients and administering the drug in a controlled clinical setting, something that was not possible without FDA clearance.

According to the announcement, the upcoming study will be randomized, double blind and placebo controlled, a design considered the gold standard for testing whether a new drug actually works. Researchers plan to measure efficacy, safety and tolerability in people living with MS, tracking both clinical symptoms and radiological changes in the brain. Site selection and other trial start-up activities are already underway, with patient enrollment expected to begin as soon as possible.

What sets Lucid-MS apart from most existing MS therapies is its mechanism. The compound is designed to protect nerve cells by inhibiting demyelination, the breakdown of the fatty sheath that insulates nerve fibers. This sheath is critical in allowing the brain to communicate effectively with the rest of the body. Most currently approved MS drugs instead work by suppressing or modulating the immune system, an approach that can leave patients vulnerable to infections and other side effects.

Lucid-MS targets an enzyme called peptidyl arginine deiminase 2, or PAD2, which has been implicated in the breakdown of myelin when its activity is increased. In preclinical models, the compound demonstrated the ability to protect the myelin sheath from this type of damage, supporting its potential as a neuroprotective approach in MS. The company notes that the compound also was not found to suppress the immune system, distinguishing its proposed approach from most currently marketed treatments.

Before reaching this milestone, Lucid-MS completed phase 1 clinical trials in healthy human volunteers. Quantum BioPharma reported that the drug showed a favorable safety profile and was well tolerated in that earlier testing, an important precondition for moving into a patient population. The underlying science behind the compound has also been published in peer-reviewed journals, including the Journal of Medicinal Chemistry and the Proceedings of the National Academy of Sciences.

Quantum BioPharma also disclosed its financial position alongside the clinical update. The company reported approximately $10 million in cash, digital assets and liquid investments as of June 30, 2026, providing some runway as it moves into the more resource-intensive phase 2 stage of development.

There is no cure for multiple sclerosis today, and the disease remains a leading cause of neurological disability among young adults. The FDA’s clearance does not guarantee that Lucid-MS will ultimately prove effective or reach the market; all drug candidates that begin clinical trials do not receive final approval. Phase 2 testing exists specifically to answer the question of a drug’s effectiveness and safety, gathering real-world data on how the drug performs against a placebo in an actual patient population.

However, for a company still in the clinical stage of development, an FDA clearance represents significant forward momentum. Investors and patients alike will likely be watching for updates on site activation, enrollment progress and eventual trial data as Quantum BioPharma works to advance a treatment approach it believes is fundamentally different from what is currently available.

For more information, visit www.QuantumBioPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM

• In today’s AI space, the holdup in growing the AI space is no longer chips but electricity.
• Azio AI’s strategy centers on securing power first, then layering compute capacity on top of it.
• The company frames its approach as full spectrum, selling GPU systems, hosting AI and high-performance computing workloads, and generating the power that keeps all of it running.

Every new AI model announced this year needs somewhere to run, and increasingly, that somewhere does not yet exist. Azio AI Holdings (NASDAQ: AZIO) is committed to closing that gap, building the data centers, GPU systems and power infrastructure that turn AI ambition into working compute.

Once upon a time, the bottleneck holding back the industry was chips, but that has changed. In today’s AI space, the holdup is electricity. Goldman Sachs Research estimates that U.S. data center power demand will climb from 31 gigawatts in 2025 to 41 gigawatts in 2026 and 66 gigawatts in 2027. That forecast is based on U.S. data center capacity doubling to about 95 gigawatts by the end of 2027.

Meeting that curve requires new construction at a pace the power grid was not built for. Goldman Sachs analysts expect data center capacity additions to jump to 13.6 gigawatts in 2026 and 36.3 gigawatts in 2027, compared with just 6.4 gigawatts added in 2024. Securing power for a site rather than securing GPUs has become the harder problem for developers to solve.

Spending is following that demand. The International Data Corporation projects global AI infrastructure spending will reach $487 billion in 2026 and surpass more than a trillion dollars by 2029. That growth has pulled a wave of new entrants into data center development, power generation and GPU hosting.

I would remove reference to me being President and updating numbers to 512 GPU units of pipeline sales, the sales amount and this new figure can be found in our latest PR from today. AZIO AI Holdings is an integrated compute infrastructure platform, spanning GPU and compute system sales, energy-backed AI hosting and company-operated Bitcoin mining. Led by an experienced executive team, including CEO and chair Chris Young with CFT Jason Maddox, the company follows a strategy focused on securing power first, then layering compute capacity on top of it.

That strategy is playing out in south Texas, where the company controls more than 548 acres of land engineered for up to 500 megawatts of behind-the-meter power capacity. Behind-the-meter power comes from generation built directly on site, letting a developer bypass years-long utility interconnection queues. The company’s most recent announcement unveiled the official name of the first stage of this project: Atlas One. 

Azio AI Holdings has secured approximately 11 megawatts of behind-the-meter natural gas power at that site and activated about 6 megawatts for an initial workload. It has also signed a master services agreement with AT&T for dedicated fiber connectivity, committing roughly 2.4 million dollars to the project.

On the hardware side, Azio AI Holdings has agreed to sell up to 512 NVIDIA HGX B300 GPU systems to Power Champion Investment Limited, in a deal the company estimates could be worth approximately $307 million. This agreement builds on earlier hosting agreements the two companies signed in July and earlier this month. 

The company frames its approach as full spectrum, selling GPU systems, hosting AI and high-performance computing workloads, and generating the power that keeps all of it running. That combination is meant to let Azio AI participate across multiple parts of the AI compute value chain rather than depending on a single hardware transaction or contract.

Azio AI Holdings still has work ahead to convert its land, power and hardware agreements into contracted, revenue-generating AI hosting capacity. The company has noted that its planned 500 megawatt buildout depends on additional financing, permitting and customer commitments. Even so, the company’s movement reflects a broader shift underway across the AI industry, where physical infrastructure has become as important as the models running on top of it. As compute demand keeps outpacing available power, companies that can deliver both are positioning themselves at the center of the buildout.

For more information, visit www.AzioAI.ai.

NOTE TO INVESTORS: The latest news and updates relating to AZIO are available in the company’s newsroom at https://ibn.fm/AZIO

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

• SuperQ has commercialized its Super(TM) hybrid quantum and high-performance computing platform while advancing Super OS(TM) and the Super Nova(TM) hybrid quantum computer for data center, enterprise and secure on-site deployment.
• The company addresses multiple commercial applications through a portfolio spanning advanced optimization, post-quantum cybersecurity, consumer-facing quantum computing and tactical decision-support technology.
• SuperQ is expanding into U.S. defense and dual-use markets through the Canada and Q-Branch Dual-Use Accelerator and conducted a live operational field demonstration at the Bush Combat Development Complex in August 2026.
• The company secured a commercial agreement with AI Financial Corporation in May 2026 covering deployment of SuperPQC(TM) post-quantum security and integration of Super(TM) hybrid computing into digital asset infrastructure.
• SuperQ is pursuing international commercialization through activities spanning Canada, the U.S., Middle East, Asia and Europe, supported by its expanding Super Hub network and government-backed market-entry initiatives.

SuperQ Quantum Computing (CSE: QBTQ) (OTCQB: QBTQF) is a quantum and supercomputing company focused on reducing the technical and financial barriers to commercial adoption of advanced computing. The company combines quantum computing with classical high-performance computing to address complex optimization, cybersecurity and decision-making challenges for enterprises, governments and research institutions.

SuperQ’s approach is centered on making advanced computational resources more accessible and commercially practical through an integrated ecosystem of software, hardware and AI-driven technologies. The company is developing solutions intended to move quantum computing beyond specialized research environments and into practical enterprise, institutional and consumer applications.

Through its technology development and expanding international ecosystem, SuperQ is pursuing broader adoption of quantum and supercomputing across commercial, government and research environments. The company is also establishing regional hubs to provide access, training and expert guidance around emerging computing technologies.

SuperQ Quantum is headquartered in Canada, with a growing international presence particularly in the U.S., Middle East and Asia.

Products and Technology

Super(TM) Platform

Super(TM) is SuperQ’s commercialized hybrid quantum and supercomputing platform. The platform uses proprietary AI agents, called Super Autopilots, to autonomously build and execute solutions to complex optimization and cybersecurity problems. Its Super Optimizer capabilities span problem modeling and decomposition, mathematical optimization, AI model optimization, GPU computing, gate-based quantum computing and quantum annealing, along with the interpretation and visualization of results.

SuperQ is applying the platform to complex optimization and decision-making challenges across industries including logistics, energy, healthcare, transportation and manufacturing. The company also provides professional services to support product deployment and help organizations model and solve industry-specific challenges using the platform.

SuperPQC(TM)

SuperPQC(TM) is the company’s post-quantum cybersecurity suite, designed to assess cryptographic vulnerabilities and support migration toward quantum-resistant security. In May 2026, SuperQ announced a commercial agreement with AI Financial Corporation to deploy SuperPQC(TM) across its technology stack and integrate Super(TM) hybrid quantum computing into its digital asset infrastructure.

Super Edge(TM)

Super Edge(TM) extends the company’s technology into tactical and distributed operating environments. In August 2026, SuperQ deployed the technology during a live operational field demonstration at the Bush Combat Development Complex at Texas A&M University’s RELLIS Campus, where Super Edge(TM) and the Super(TM) platform were evaluated for real-time decision support, dynamic route optimization, post-quantum secured communications and edge-to-command integration.

ChatQLM(TM)

ChatQLM(TM) is SuperQ’s consumer-facing application powered by its proprietary Quantum Leveraged Model technology. The application combines conversational AI with access to quantum and high-performance computing, allowing users to describe complex problems in natural language while the system translates those requests into computational models and routes them to appropriate computing resources.

ChatQLM(TM) includes general AI functionality and quantitative decision-making applications alongside access to quantum simulators, quantum computers, visual quantum programming and educational resources. Through ChatQLM(TM), SuperQ is seeking to make quantum and supercomputing capabilities accessible to consumers without requiring specialized technical expertise.

Super OS(TM)

Super OS(TM) is an operating system under development to unify quantum and supercomputing for data center and enterprise deployment. It is being designed as an orchestration layer across heterogeneous computing infrastructure, enabling interoperability among classical CPUs, GPUs and quantum processing units. Super OS(TM) is intended to run on both SuperQ’s own hardware and supported third-party quantum computers.

Super Nova(TM)

Super Nova(TM) is SuperQ’s in-development modular hybrid quantum computer designed to run Super OS(TM) natively. Its proposed architecture combines quantum and classical processing through modular compute stacks that can be added or removed based on deployment requirements. SuperQ is targeting the technology for data center, enterprise and secure on-site deployments.

Super Hub

Super Hub is a global network designed to reduce technical and financial barriers to advanced technologies by providing physical access points to powerful remote hybrid computing systems across international borders. Located near communities worldwide, these experience zones are intended to host masterclasses, webinars, workshops and hackathons while supporting dedicated quantum technology interest groups. SuperQ serves as a catalyst for Super Hub locations to scale a global, decentralized model inspired by AT&T Bell and other leading laboratories, creating collaborative spaces where international community members can meet and develop solutions to complex global challenges. The network includes Canada’s first Quantum Super Hub in Lethbridge, eight hubs across Alberta and Asia’s first Super Hub at Sharjah Research Technology and Innovation Park’s SoiLAB in the UAE, with further international expansion planned across Asia.

Market Opportunity

SuperQ is targeting commercial opportunities spanning enterprise computing, post-quantum cybersecurity, defense and dual-use technology. According to figures cited by the company in July 2026, global private venture capital investment in defense technology reached a record $49.9 billion across 966 deals, nearly doubling year over year. The company also cited the U.S. dual-use venture market at $49 billion and the global GovTech dual-use platform market at $24.7 billion in 2025.

SuperQ further reported that the U.S. Department of Defense committed more than $17.5 billion in 2025 to emerging technologies including quantum computing and post-quantum cybersecurity. The company is engaging this market through the Canada and Q-Branch Dual-Use Accelerator, Fed Supernova 2026 and its August 2026 live operational demonstration at the Bush Combat Development Complex.

International expansion extends to Europe, where company materials identify the €22 million Quantum Spain initiative and €43 million Vall de la Quàntica program as investments supporting Barcelona’s quantum and deep-tech ecosystem. SuperQ was selected for a Canadian government-backed Deep Tech Innovation Mission to Barcelona, where it intends to showcase applications of its technology for mobility, decentralized energy, smart-city planning and other infrastructure challenges.

Leadership Team

Dr. Muhammad Ali Khan, Founder, Chief Executive Officer and Board Chair, is a Silicon Valley entrepreneur, technology executive and scientist with more than 20 years of experience spanning artificial intelligence, quantum computing and optimization in industry and academia. He has built and scaled private and public companies in Canada, the San Francisco Bay Area and the UAE and previously worked at universities around the world after graduating from the University of Cambridge. A Rhodes Scholar, Cambridge Commonwealth Scholar, Vanier Scholar and Killam Scholar, Dr. Khan has also advised and invested in startups and regularly participates in major technology conferences.

Krishna Ganesh, Chief Operating Officer and Director, is a seasoned data scientist, entrepreneur and technology consultant with experience in generative AI and supply chain applications. His background includes work as a Big Four technology consultant, and he serves on SuperQ’s board alongside his operational leadership responsibilities.

Manoj Joseph, Chief Business Officer and Director, is an enterprise business leader focused on business model innovation, cross-border market expansion and strategic partnerships. His experience includes B2B enterprise sales, partnership development and community building, and he also serves as a director of SuperQ.

For more information, visit the company’s website at https://www.superq.co.

NOTE TO INVESTORS: The latest news and updates relating to QBTQF are available in the company’s newsroom at https://ibn.fm/QBTQF

• In the United States alone, close to one million people are living with MS, with a landmark study finding that figure was more than double what had previously been assumed.
• Treatments for progressive forms of MS remain especially elusive, and recent research notes that no currently approved therapy directly reverses the neurodegeneration that drives long-term disability.
• Quantum BioPharma’s Lucid-MS candidate is designed to inhibit demyelination directly by targeting an enzyme called peptidyl arginine deiminase 2.

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its lead drug candidate: Lucid-MS.

Multiple sclerosis is a chronic disease of the central nervous system in which the immune system attacks myelin, the protective coating around nerve fibers in the brain and spinal cord. Global prevalence rose from about 2.3 million people in 2013 to roughly 2.8 million in 2020 and had climbed to an estimated 2.9 million by 2023.

In the United States alone, close to one million people are living with the disease. A landmark study published in the journal “Neurology” found the figure was more than double what had previously been assumed for decades. The disease typically strikes people in their 20s and 30s, with women being diagnosed at roughly twice the rate of men.

The symptoms of MS can be unpredictable and wide ranging. They include fatigue, vision problems, numbness, balance and coordination trouble, and cognitive changes, all stemming from damaged communication between the brain and the rest of the body. Because the disease can progress differently in every patient, diagnosis and treatment planning remain genuinely difficult for physicians.

Most currently available therapies fall into a category called disease-modifying therapies, and the majority of these treatments work by suppressing or modulating the immune system. Interferons, glatiramer acetate and newer monoclonal antibodies are among the most widely prescribed options, and research shows these drugs can meaningfully reduce relapse rates for people with relapsing forms of the disease.

But that same body of research points to real limitations. Injectable immunomodulatory therapies suffer from poor long-term adherence, with roughly half of patients discontinuing treatment within the first year, according to the same published review. Treatments for progressive forms of MS remain especially elusive, and recent research notes that no currently approved therapy directly reverses the neurodegeneration that drives long-term disability.

That gap between managing relapses and actually protecting nerve tissue is where newer approaches are working to make progress. Researchers are increasingly interested in neuroprotective and remyelinating strategies, ones that aim to preserve or restore the myelin sheath itself rather than only calming the immune system’s attack on it.

Quantum BioPharma’s Lucid-MS candidate fits into that emerging category. Rather than suppressing immune activity, the compound is designed to inhibit demyelination directly by targeting an enzyme called peptidyl arginine deiminase 2, which when overactive has been linked to myelin breakdown. Quantum reports that in preclinical animal studies, the compound prevented myelin degradation, and findings from that research have appeared in peer-reviewed outlets, including the Journal of Medicinal Chemistry and Proceedings of the National Academy Sciences.

The company recently reached a significant milestone in its efforts. The FDA cleared Quantum BioPharma’s Investigational New Drug (“IND”) application for Lucid-MS, allowing the company to move the candidate into phase 2 clinical trials. That stage of testing is designed to evaluate whether the drug is effective in treating MS in a controlled patient population and also allows for continued safety monitoring.

The global market for MS therapeutics reflects just how much is riding on finding better options. Precedence Research estimates that market at approximately $34.8 billion in 2025, with projections suggesting it could nearly double by 2035 as new mechanisms of action reach patients.

For the millions of people currently living with multiple sclerosis, and the hundreds of thousands more diagnosed each year, incremental progress in the lab eventually has to translate into new choices at the pharmacy. Quantum BioPharma is one of several companies working toward that goal, betting that protecting nerve tissue directly, rather than only quieting the immune system, could open a new chapter in how the disease is treated.

For more information, visit www.QuantumBioPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM

• California’s SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force policies, but no policy can guarantee that verbal techniques will resolve an encounter.
• Wrap Technologies has completed a doctrine combining communication, recognition of resistance, positioning and remote restraint into a framework intended to operationalize de-escalation.
• The curriculum is undergoing independent validation ahead of an application for California POST certification, with digital delivery through Wrap Tactics planned if certification is obtained.

De-escalation has moved from a recommended practice to a formal part of law enforcement policy and training. California’s Senate Bill 230 required every law enforcement agency in the state to maintain a use-of-force policy incorporating de-escalation techniques, crisis intervention tactics and other alternatives to force when feasible. It also directed the Commission on Peace Officer Standards and Training (“POST”) to implement regular and periodic use-of-force instruction that includes tactical methods using time, distance, cover and concealment.

Those requirements establish what officers should attempt. They cannot make another person cooperate. An officer can communicate, persuade, slow the situation and issue lawful commands, yet the person involved may remain unable or unwilling to comply. Wrap Technologies Inc. (NASDAQ: WRAP) has developed a doctrine around what an officer can do when verbal efforts are not working but circumstances do not yet call for a traditional weapons-based response.

The Space Between 

Verbal de-escalation remains the foundation of the methodology WRAP announced on September 2. The doctrine combines communication, recognition of resistance, time, distance, tactical positioning and remote restraint within a single framework built around one question: what can an officer lawfully and tactically do when verbal de-escalation has reached its limit?

Conventional options move toward hands-on control or tools that operate through chemical, electrical or kinetic effects, each carrying greater risk for officers and the people they are attempting to restrain. WRAP positions the BolaWrap(R) 150 as an additional option within that gap: rather than relying solely on voluntary compliance, the methodology is intended to give an officer a physical capability that may help create the conditions for de-escalation.

The doctrine does not eliminate higher-force options. Officers retain the ability to transition to other lawful tools if the resistance or threat changes. WRAP calls the principle the “Lowest Reasonable Response”: identify an effective response appropriate to the resistance and circumstances, then continuously reassess the encounter.

Why the ATF Classification Matters

The doctrine follows ATF Ruling 2026-2, which determined that the BolaWrap(R) 150, as currently designed, is neither a firearm nor an “any other weapon” under federal law. The ruling identifies it as an instrument of restraint, while WRAP describes it as an instrument of restraint and rescue.

The handheld device deploys an eight-foot Kevlar tether around a person’s arms or legs from a range of 10 to 25 feet. It is designed to restrain without relying on electrical incapacitation, chemical irritants, pain compliance or a conventional impact projectile.

The ATF classification gives WRAP a foundation for developing doctrine around remote restraint as a distinct operational category. It does not determine whether any particular deployment is legally justified. That still depends on the facts of the encounter, applicable law and agency policy.

Addressing Behavioral and Mental Health Calls

WRAP sees the most relevant application in behavioral and mental health emergencies, where a person may be unable, rather than simply unwilling, to understand commands or respond to persuasion. An officer can follow accepted communication practices and still reach the end of the verbal playbook with the unresolved encounter.

Specialized Crisis Intervention Teams exist for these calls, but they cannot be present for every encounter. As WRAP puts it, the patrol officer is often the crisis intervention team until the crisis intervention team arrives.

The methodology is intended to bring crisis intervention principles closer to the point of first contact, with a defined sequence for recognizing crisis behavior, creating time and distance, considering remote restraint when appropriate, reassessing and transitioning to other lawful options if conditions change.

From Doctrine to Standardized Training

WRAP has submitted the curriculum for independent validation in preparation for applying for California POST certification. Neither validation nor certification is assured.

If certified, the curriculum would give California agencies a standardized methodology for incorporating the BolaWrap(R) 150 and operational de-escalation into patrol, crisis-response and agency training, distributed digitally through WRAP Tactics(TM), WRAP’s learning management system.

The Task Force 70 Foundation, a nonprofit law enforcement training organization, is supporting the doctrine, curriculum structure and instructor credentialing. WRAP believes recognized training could reduce adoption barriers by letting agencies evaluate the device alongside a defined operational framework, and digital delivery would add a recurring training component alongside device and cassette sales.

WRAP intends to use the California process as a model for seeking recognition in additional states. The company reports that BolaWrap(R) 150 has been adopted by more than 1,000 agencies in the United States and more than 60 countries.

De-escalation policies tell officers what they should attempt to accomplish. WRAP’s doctrine seeks to define what may come next when communication alone does not resolve the encounter. Whether it becomes a recognized operational standard will depend on validation, certification and its eventual performance in agency training and field use.

For more information, visit the company’s website at wrap.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies, Inc. or its management, including any forward-looking statements regarding revenue growth, product development, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

• The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and changes in the mortgage and housing markets.
• The production is scheduled to begin distribution the week of Sept. 21 through BizTV, American Life Network and American Forces Network.
• The three networks have a combined potential audience of approximately 90 million viewers, according to Beeline.
• The program examines mortgage affordability, interest rates, housing inventory, alternative underwriting, automation and access to home equity.
• Beeline operates a digital mortgage and financial technology platform serving both homebuyers and real estate investors.
• The company’s strategy includes mortgage products for younger borrowers, including consumers seeking investment properties, as well as equity-focused products for homeowners with substantial accumulated home equity.

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform offering a more efficient path to homeownership, has partnered with Emmy Award-winning Loft 100 Studios on a new documentary-style production examining developments in the mortgage industry and changing approaches to homeownership (https://ibn.fm/RZsjX).

The 45-minute production, described as a “Bizumentary,” is scheduled to begin distribution during the week of September 21 through BizTV, American Life Network and American Forces Network. According to Beeline, the networks have a combined potential reach of approximately 90 million viewers. The company said the production could subsequently be considered for distribution through larger networks as it gains exposure.

The program examines several issues affecting the housing and mortgage markets, including affordability, interest rates, housing inventory, and changes in how consumers obtain mortgage financing and access home equity. It also features perspectives from business executives and other participants in the housing and financial-services markets.

The production was developed with Loft 100 Studios, a full-service production company whose team and productions have received Emmy recognition. The program combines documentary-style interviews and business commentary with an examination of technologies and financial products being developed within the mortgage market.

For Beeline, the production provides an opportunity to discuss its digital mortgage platform alongside broader changes taking place in housing finance. “The mortgage industry is at an important turning point,” said Nick Liuzza, CEO of Beeline. “Affordability remains a challenge, but innovation is creating new solutions. Non-traditional mortgage products are gaining popularity because they solve real problems for borrowers, while technology and automation are making financing faster, simpler and more accessible.”

Beeline operates through its wholly owned subsidiary, Beeline Loans Inc., providing mortgage financing for primary homebuyers and real estate investors. The company has built its lending platform around artificial intelligence and automation. Its technology includes Bob, an AI-powered mortgage assistant, and Hive, a proprietary mortgage production engine.

Beeline says its digital lending process can support loan closings in approximately 14 to 21 days. The company also reports a Net Promoter Score above 80, a metric used to measure customer satisfaction and willingness to recommend a service.

The company’s target market extends beyond consumers purchasing a primary residence. Beeline has developed mortgage products that address borrowers seeking real estate investment properties. This segment includes younger consumers who may be entering property ownership through investment rather than purchasing a home solely for personal use.

The approach is relevant as younger generations continue to face barriers to traditional homeownership. Data cited by the National Mortgage Professional indicated that 26.1% of Gen Z respondents and 54.9% of Millennials were homeowners in 2024. Limited access to mortgage financing and housing affordability have been among the factors affecting younger buyers.

Beeline has sought to use automation to shorten the initial mortgage qualification process. The company says its AI technology can provide an initial decision within approximately seven to eight minutes and give prospective borrowers an estimated 90% certainty regarding whether they qualify.

Homeowners who have accumulated significant equity represent another potential market for financial products. Beeline has identified approximately $10 trillion of U.S. home equity as an addressable opportunity and is developing solutions intended to give homeowners greater access to that capital.

For more information, visit the company’s website at www.MakeABeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at  https://ibn.fm/BLNE